Lonza Group AG | WebDisclosure

Basculer en Français

8295	Companies
114850	Keywords
55292	Articles
62440	Press releases

Home
Companies
Lonza Group AG

BRIEF

published on 10/03/2024 at 09:05, 1 month 18 days ago

Lonza nomme David Meline au poste de membre indépendant du conseil d'administration

Conseil D'administration Assemblée Générale Annuelle Expérience Financière Groupe Lonza David Meline
PRESS RELEASE

published on 10/03/2024 at 09:00, 1 month 18 days ago

Lonza Nominates David Meline as Independent Board Member
Lonza nominates David Meline, experienced CFO, for Board position. Olivier Verscheure not to seek re-election. Details on David's background and Lonza's activities

CFO Lonza Board Member David Meline Olivier Verscheure
BRIEF

published on 10/01/2024 at 16:50, 1 month 19 days ago

Lonza finalise l'acquisition d'un site de produits biologiques à grande échelle à Vacaville

Acquisition Lonza Médicaments Produits Biologiques Vacaville
BRIEF

published on 10/01/2024 at 16:50, 1 month 19 days ago

Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville

Acquisition Pharmaceuticals Lonza Biologics Vacaville
PRESS RELEASE

published on 10/01/2024 at 16:45, 1 month 19 days ago

Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche
Lonza completes acquisition of large-scale biologics site in Vacaville (US) from Roche, expanding US footprint and manufacturing capacity

Acquisition Manufacturing Lonza Roche Biologics
BRIEF

published on 09/24/2024 at 14:05, 1 month 26 days ago

Lonza and Vertex Sign Long-Term Supply Agreement for CASGEVY®

Lonza Cell Therapy Vertex CASGEVY® CRISPR/Cas9
BRIEF

published on 09/24/2024 at 14:05, 1 month 26 days ago

Lonza et Vertex signent un accord d'approvisionnement à long terme pour CASGEVY®

Lonza Sommet Thérapie Cellulaire CASGEVY® CRISPR/Cas9
PRESS RELEASE

published on 09/24/2024 at 14:00, 1 month 26 days ago

Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
Lonza and Vertex sign a long-term commercial supply agreement for CASGEVY® cell therapy based on CRISPR/Cas9 gene-editing technology. Lonza to manufacture at Geleen, NL facility approved by FDA, EMA, and MHRA

Lonza Cell Therapy Vertex CASGEVY® CRISPR/Cas9
BRIEF

published on 08/28/2024 at 18:36, 2 months 23 days ago

Lonza Prices EUR 1.2 Billion Dual-Tranche Straight Bonds

Lonza EUR 1.2 Billion Corporate Financing Dual-Tranche Bonds Luxembourg Listing
BRIEF

published on 08/28/2024 at 18:36, 2 months 23 days ago

Lonza fixe le prix d'une émission d'obligations à deux tranches de 1,2 milliard d'euros

Lonza Financement Des Entreprises Obligations À Double Tranche 1,2 Milliard D'euros Cotation Au Luxembourg

Accesswire

Published on 11/21/2024 at 11:30, 23 minutes ago

FireFox Trenching Returns More High-Grade Gold at the Mustajärvi Gold Project in Lapland, Finland
Published on 11/21/2024 at 10:03, 1 hour 50 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 1 hour 53 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 2 hours 53 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 11 hours 18 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 11:30, 23 minutes ago

APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 11:01, 52 minutes ago

Original-Research: SMT Scharf AG (von Montega AG): Kaufen
Published on 11/21/2024 at 11:00, 53 minutes ago

First Patient Treated in Phase I/II Trial in Acute Myeloid and Acute Lymphoblastic Leukemia with Lu177-PentixaTher, Expanding the Evidence Base for Targeted Radiotherapy Approach
Published on 11/21/2024 at 10:56, 57 minutes ago

ABO Energy closes sale for two Battery Projects in South Africa
Published on 11/21/2024 at 10:30, 1 hour 23 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024

Les Echos

Published on 11/21/2024 at 06:58, 4 hours 55 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 55 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 4 hours 55 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 15 hours 46 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 16 hours 33 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE